#Flash: Evolocumab Add-On for familial hypercholesterolemia
Repatha (evolocumab) injection has been authorized by the FDA as an add-on treatment to diet alone or in combination with certain other treatments for patients aged 10 years and older with heterozygous familial hypercholesterolemia and homozygous familial hypercholesterolemia. Repatha helps to lower low-density lipoprotein cholesterol, sometimes known as "bad cholesterol."

If you find this post insightful, please like, comment and share.

For more details, please read: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-add-drug-ages-10-rare-forms-high-cholesterol?utm_medium=email&utm_source=govdelivery
Like
Comment
Share